← All diseases
Brain and nervous system
Multiple sclerosis (progressive)
Do you want to receive a message when there is new research on Multiple Sclerosis (Progressive)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you see one sentence explaining what was investigated — and you'll be notified as soon as new research on Multiple sclerosis (progressive) is published. View what Premium costs.
Publications and studies (1542)
- Multi-compartment Myelin Streamline Decomposition reveals tract-specific and global brain network myelination in Multiple Sclerosis. (2026/07/17) ♡
- AI-based predictive biomarkers for chronic neurological diseases: the rAIdD prospective, multicenter, observational study protocol. (2026/07/17) ♡
- Chitinase-1 in cerebrospinal fluid and white matter injury in patients with progressive multiple sclerosis. (2026/07/15) ♡
- Honokiol attenuates neuroinflammation and enhances remyelination in mouse models of multiple sclerosis through PPARγ-mediated ERK/AKT signalling. (2026/07/14) ♡
- Cross-platform comparison of blood glial fibrillary acidic protein quantification in healthy controls and multiple sclerosis. (2026/07/14) ♡
- The ILLUMINATE natural history study in colony-stimulating factor 1 receptor-related adult-onset leukoencephalopathy with axonal spheroids and pigmented glia. (2026/07/14) ♡
- Clinical course of critical demyelinating lesion-associated progressive multiple sclerosis. (2026/07/13) ♡
- Neurofilament light chain as a tool for assessing disease activity and treatment response in Multiple Sclerosis. (2026/07/13) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Pontine autosomal dominant microangiopathy with leukoencephalopathy in a Hispanic man without a family history. (2026/07/12) ♡
- Label-Free Myelin Fingerprinting: An Adult Human Post-Mortem Brain Slice Platform via Coherent Anti-Stokes Raman Spectroscopy. (2026/07/11) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. From measurement to biomarker trajectories: platform-agnostic Z score analysis of serum NfL and GFAP in ocrelizumab-treated multiple sclerosis. (2026/07/10) ♡
- EBV-informed multi-omics target prioritization and structure-based drug repurposing reveal potential therapeutic strategies for multiple sclerosis. (2026/07/09) ♡
- Challenges and future directions for multiple sclerosis after the 2024 McDonald diagnostic criteria. (2026/07/09) ♡
- Features and management of kidney manifestations of tuberous sclerosis complex: a real-world study in a Brazilian patient cohort. (2026/07/09) ♡
- Assessment of treatment response in recurrent medulloblastoma using craniospinal MRI. (2026/07/09) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The autophagy-senescence-inflammasome axis: A novel triad in neurodegenerative diseases? (2026/07/08) ♡
- Application of serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) as biomarkers in the clinical management of multiple sclerosis (NeuroFilMS): a protocol for an observational cohort study. (2026/07/08) ♡
- In-clinic validation of a smartphone-based finger tapping test for use in neurodegenerative and neurological populations. (2026/07/07) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Distance Is Brain: Reflections of a Young Neurologist. (2026/07/07) ♡
- Diagnostic overshadowing in primary progressive multiple sclerosis with coexisting tethered cord syndrome and long-standing urological dysfunction: a case report and literature review. (2026/07/06) ♡
- Regional mapping of CSF1R-positive microglia in neurodegenerative diseases and progressive MS, with exploratory presynaptic marker analyses. (2026/07/04) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Efficacy and safety of extended-interval dosing of natalizumab in multiple sclerosis: a systematic review and meta-analysis with subgroup evaluation. (2026/07/03) ♡
- Assistive device prescriptions in multiple sclerosis: a cross-sectional study of disability distribution. (2026/07/03) ♡
- Single-center longitudinal experience with MRgLITT in pediatric neurosurgery: technical evolution, expanding indications, and advanced MRI-driven planning. (2026/07/03) ♡
- A Review on the Mechanisms of Neurodegeneration and the Potential of Plant Bioactives in Managing Neurological Conditions. (2026/07/03) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Advances in Multiple Sclerosis. (2026/07/02) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Comorbid autoimmune disease in stiff-person syndrome spectrum disorder: a systematic review and meta-analysis. (2026/07/02) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. The dual role of mTOR in multiple sclerosis pathophysiology: a systematic review. (2026/07/02) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Gerstmann-Sträussler-Scheinker disease mimicking primary progressive multiple sclerosis: A case with positive oligoclonal bands. (2026/07/01) ♡
- Impact of multiple sclerosis disease-modifying therapies on chronic lesion tissue expansion. (2026/07/01) ♡
- Heterocyclic Scaffolds as Therapeutic Agents in Multiple Sclerosis: Mechanisms and SAR Study. (2026/07/01) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Looking Beyond Dose: Identifying Responders and Non-Responders to RehaCom Computerized Cognitive Rehabilitation in Progressive MS-The CogEx Study. (2026/07/01) ♡
- NSAID use is associated with lower dementia and Alzheimer's disease prevalence and slower cognitive decline: A retrospective longitudinal analysis of the NACC cohort. (2026/06/30) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Available Biomarkers for Personalized Prognostication in Early and Very Early Systemic Sclerosis: A Narrative Review of the Current Literature. (2026/06/30) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Smoking accelerates immunosenescence in multiple sclerosis. (2026/06/29) ♡
- Investigating the Relationship Between Visual Evoked Potentials, Neurological and Neuropsychological Status in Primary Progressive Multiple Sclerosis. (2026/06/28) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The role of SUMOylation in regulating proteins that drive neuronal disease progression. (2026/06/26) ♡
- Three-Dimensional Deep Learning with Routine Brain Magnetic Resonance Imaging and Clinical Data for Identification of Secondary Progressive Multiple Sclerosis. (2026/06/26) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. T Helper Cells and Cytokine Networks in the Immunopathogenesis of Multiple Sclerosis. (2026/06/25) ♡
- Targeting cannabinoid receptor 1 for multiple sclerosis: molecular docking and dynamic insights of berberine and curcumin as potential therapeutic agents. (2026/06/25) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Serum neurofilament light chain in multiple sclerosis: from biological signal to clinically informed decision-making. (2026/06/24) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Navigating uncertainty together: a participatory mixed-method study of counseling services for couples living with multiple sclerosis. (2026/06/24) ♡
- Investigating the treatment of vascular risk with simvastatin in secondary progressive multiple sclerosis: analysis from the MS-STAT2 randomized controlled trial. (2026/06/24) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Multiple sclerosis and the limits of classical autoimmune theory. (2026/06/18) ♡
- Monocarboxylate transporter 2 regulates maintenance of myelin and axonal integrity by oligodendrocytes. (2026/06/18) ♡
- Multiple sclerosis patients under treatment with interferon β1-a or ocrelizumab exhibit different T and B cell responses to SARS-CoV-2 vaccine. (2026/06/16) ♡
- HLA-DRB1*15:01 drives sex- and age-dependent microglial immune phenotypes and neuroimmune signaling. (2026/06/16) ♡
- Subclinical Trigeminal Dysfunction in Multiple Sclerosis Detected by Pulp Sensibility Testing. (2026/06/15) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Unlocking the healing power of Berberine: A promising aid for multiple sclerosis. (2026/06/14) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Anti-N-Methyl-D-Aspartate (NMDA) Receptor Encephalitis Presenting as Acute Psychosis and Seizures in a Patient With Multiple Sclerosis: A Diagnostic Challenge. (2026/06/10) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.